date,title,source
Oct-19-18,Principia Biopharma Announces PRN1008 Receives Orphan-Drug Designation from FDA for Treatment of Immune Thrombocytopenic Purpura,GlobeNewswire
Oct-23-18,"Health Care Digest: Winning the war for biotech talent, dialysis companies spend big on Prop. 8, and more",American City Business Journals
Oct-24-18,"Principia Biopharma Appoints Dolca Thomas, M.D. as Chief Medical Officer",GlobeNewswire
